Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedJul 10, 2024
DataAggregated Company Financials
Companies61
  • 7D-1.0%
  • 3M18.1%
  • 1Y5.8%
  • YTDn/a

The Biotech is pretty flat in the last 7 days, but Tanvex BioPharma has stood out, gaining 48%. The past year has been better, since the industry has gained 5.1% in that time. As for the next few years, earnings are expected to grow by 73% per annum.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 10 Jul 2024NT$550.7bNT$21.9b-NT$11,110,643,000.0043.2x-49.6x25.1x
Fri, 07 Jun 2024NT$508.0bNT$21.9b-NT$11,110,643,000.0041.7x-45.7x23.2x
Sun, 05 May 2024NT$455.6bNT$21.6b-NT$12,502,137,000.0048.2x-36.4x21.1x
Tue, 02 Apr 2024NT$445.5bNT$20.9b-NT$10,667,106,000.0052.1x-41.8x21.3x
Thu, 29 Feb 2024NT$451.6bNT$20.7b-NT$9,591,454,000.0039.4x-47.1x21.8x
Sat, 27 Jan 2024NT$433.7bNT$19.9b-NT$9,830,596,000.0039.8x-44.1x21.8x
Mon, 25 Dec 2023NT$467.1bNT$19.9b-NT$9,737,975,000.0043.1x-48x23.5x
Wed, 22 Nov 2023NT$475.5bNT$19.4b-NT$10,027,536,000.0039x-47.4x24.5x
Fri, 20 Oct 2023NT$449.7bNT$18.4b-NT$10,823,013,000.0044.6x-41.6x24.4x
Sun, 17 Sep 2023NT$499.9bNT$18.3b-NT$10,776,417,000.0043x-46.4x27.3x
Tue, 15 Aug 2023NT$451.8bNT$18.9b-NT$10,207,311,000.0045x-44.3x23.9x
Thu, 13 Jul 2023NT$468.7bNT$18.7b-NT$10,725,166,000.0043.6x-43.7x25.1x
Sat, 10 Jun 2023NT$490.9bNT$17.6b-NT$11,251,141,000.0043.4x-43.6x27.9x
Mon, 08 May 2023NT$529.2bNT$18.5b-NT$9,923,392,000.0045.7x-53.3x28.6x
Wed, 05 Apr 2023NT$499.9bNT$20.3b-NT$9,157,006,000.0043.9x-54.6x24.6x
Fri, 03 Mar 2023NT$528.5bNT$22.3b-NT$7,093,875,000.0038x-74.5x23.7x
Sun, 29 Jan 2023NT$494.2bNT$21.8b-NT$7,778,690,000.0036.2x-63.5x22.7x
Tue, 27 Dec 2022NT$497.1bNT$21.8b-NT$7,778,690,000.0036.4x-63.9x22.8x
Thu, 24 Nov 2022NT$527.4bNT$21.8b-NT$7,522,211,000.0036.5x-70.1x24.2x
Sat, 22 Oct 2022NT$450.9bNT$23.1b-NT$6,633,590,000.0035.1x-68x19.5x
Mon, 19 Sep 2022NT$632.2bNT$23.1b-NT$6,633,590,000.0042.6x-95.3x27.4x
Wed, 17 Aug 2022NT$558.2bNT$23.6b-NT$5,600,931,000.0030.8x-99.7x23.7x
Fri, 15 Jul 2022NT$513.8bNT$22.5b-NT$5,642,821,000.0029.9x-91.1x22.8x
Sun, 12 Jun 2022NT$527.8bNT$22.5b-NT$5,642,821,000.0033.2x-93.5x23.4x
Tue, 10 May 2022NT$522.4bNT$21.7b-NT$5,726,051,000.0042.2x-91.2x24.1x
Thu, 07 Apr 2022NT$540.8bNT$21.5b-NT$5,761,086,000.0030.8x-93.9x25.2x
Sat, 05 Mar 2022NT$516.2bNT$18.0b-NT$5,619,404,000.0025x-91.9x28.7x
Mon, 31 Jan 2022NT$433.6bNT$17.9b-NT$5,532,702,000.0024.7x-78.4x24.2x
Wed, 29 Dec 2021NT$448.4bNT$17.9b-NT$5,579,296,000.0025.4x-80.4x25x
Fri, 26 Nov 2021NT$386.8bNT$17.9b-NT$5,579,296,000.0022.1x-69.3x21.6x
Sun, 24 Oct 2021NT$349.0bNT$15.4b-NT$7,624,179,000.0021.3x-45.8x22.7x
Tue, 21 Sep 2021NT$380.2bNT$15.4b-NT$7,624,179,000.0021.4x-49.9x24.7x
Thu, 19 Aug 2021NT$382.8bNT$15.4b-NT$7,624,179,000.0019.6x-50.2x24.9x
Price to Earnings Ratio

-52.3x


Total Market Cap: NT$398.7bTotal Earnings: -NT$7,624,179,000.00Total Revenue: NT$15.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -62.5x202220232024
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Biotechnology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 24.1x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 13% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Taiwanese Biotech compare with similar industries?

TW Market4.08%
Healthcare-1.73%
Biotech-0.99%
Biotech-0.99%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6541 Tanvex BioPharmaNT$72.9020.1%
+NT$2.0b
1.3%PS345.3x
6696 Lin BioScienceNT$109.5014.1%
+NT$1.1b
9.0%PB4x
4174 OBI PharmaNT$62.602.1%
+NT$298.0m
-34.0%PS293.5x
4160 Genetics Generation AdvancementNT$124.008.3%
+NT$241.3m
247.4%PE89.3x
4726 Mycenax BiotechNT$58.901.4%
+NT$164.7m
46.7%PS20.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4728

NT$327.00

Sunmax Biotechnology

7D

-3.4%

1Y

46.6%

6446

NT$576.00

PharmaEssentia

7D

-0.3%

1Y

69.2%

6541

NT$72.90

Tanvex BioPharma

7D

20.1%

1Y

1.3%

6539

NT$74.70

DV Biomed

7D

-50.2%

1Y

-60.2%

4160

NT$124.00

Genetics Generation Advancement

7D

8.3%

1Y

247.4%

6550

NT$70.70

Polaris Group

7D

-3.4%

1Y

-10.4%

6617

NT$136.00

Gongwin Biopharm Holdings

7D

-4.9%

1Y

-42.4%

4174

NT$62.60

OBI Pharma

7D

2.1%

1Y

-34.0%

1783

NT$45.40

Maxigen Biotech

7D

-9.9%

1Y

-21.3%

4726

NT$58.90

Mycenax Biotech

7D

1.4%

1Y

46.7%

4168

NT$30.35

GlycoNex Incorporation

7D

2.4%

1Y

0.5%

4147

NT$84.10

TaiMed Biologics

7D

-3.8%

1Y

-10.0%

4195

NT$20.30

Genomics BioSci & Tech.Ltd

7D

6.3%

1Y

-15.3%

1295

NT$71.00

Synbio Tech

7D

7.1%

1Y

n/a

6875

NT$65.80

Pharmosa Biopharm

7D

-4.4%

1Y

-35.2%

6696

NT$109.50

Lin BioScience

7D

14.1%

1Y

9.0%